Ticker League

EBITDA Margin for Boston Scientific (BSX)

As of · Reported

Metric

TTM

23.1%

YoY change

−4.92pp

Trough year (2012)

-43.6%

Peak year (2004)

32.6%

EBITDA Margin history chart for Boston Scientific (BSX) from 1991 to 2025

Latest: 18.6%

EBITDA Margin change chart for Boston Scientific (BSX) from 1991 to 2025

Latest: −4.92pp

EBITDA Margin history table for Boston Scientific (BSX) from 1991 to 2025

  • 202518.6%-4.92pp
  • 202423.5%-0.73pp
  • 202324.2%+2.64pp
  • 202221.6%+0.43pp
  • 202121.2%+5.94pp
  • 202015.2%-5.34pp
  • 201920.6%-5.73pp
  • 201826.3%+4.13pp
  • 201722.2%+7.56pp
  • 201614.6%+9.80pp
  • 20154.8%-1.05pp
  • 20145.9%-4.23pp
  • 201310.1%+53.70pp
  • 2012-43.6%-65.06pp
  • 201121.5%+19.54pp
  • 20101.9%+3.23pp
  • 2009-1.3%+7.36pp
  • 2008-8.7%-19.93pp
  • 200711.2%+40.90pp
  • 2006-29.7%-50.26pp
  • 200520.6%-11.98pp
  • 200432.6%+5.84pp
  • 200326.8%-2.57pp
  • 200229.3%+6.35pp
  • 200123.0%-9.16pp
  • 200032.1%+0.36pp
  • 199931.8%+4.02pp
  • 199827.8%+0.57pp
  • 199727.2%-0.98pp
  • 199628.2%+1.08pp
  • 199527.1%-3.87pp
  • 199431.0%+0.71pp
  • 199330.3%-0.65pp
  • 199230.9%-1.23pp
  • 199132.1%—

EBITDA Margin values are taken from Boston Scientific's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Boston Scientific (BSX)

According to Boston Scientific's latest reported financial statements, the company's latest reported EBITDA margin is 23.1%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Boston Scientific (BSX) most recent annual EBITDA margin stands at 18.60% (2025) – contracted 4.9 percentage points year-over-year.

2004 marks the peak EBITDA margin at 32.59%, with the historical low of -43.61% recorded in 2012.

Boston Scientific EBITDA Margin by Year

Boston Scientific EBITDA Margin 2025: 18.6%

2025's EBITDA margin for Boston Scientific came in at 18.60%, contracted 4.9 percentage points from 2024.

Boston Scientific EBITDA Margin 2024: 23.5%

Boston Scientific posted EBITDA margin of 23.51% in 2024, contracted 0.7 percentage points from 2023.

Boston Scientific EBITDA Margin 2023: 24.2%

In 2023, Boston Scientific reported EBITDA margin of 24.25%, expanded 2.6 percentage points from 2022.

Boston Scientific EBITDA Margin 2022: 21.6%

Boston Scientific EBITDA margin in 2022 was 21.61%, expanded 0.4 percentage points from 2021.

Boston Scientific EBITDA Margin 2021: 21.2%

Boston Scientific EBITDA margin in 2021 was 21.18%.

See more financial history for Boston Scientific (BSX).

Sector peers by EBITDA Margin

Healthcare peers of Boston Scientific (BSX), ranked by their latest EBITDA margin

Frequently asked questions

Boston Scientific (BSX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

No dividends paid by this company.